FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma

Conditions:   Diffuse Large B Cell Lymphoma;   Transformed Indolent Non-Hodgkin's Lymphoma;   Follicular Lymphoma;   Mantle Cell Lymphoma;   Marginal Zone Lymphoma Interventions:   Drug: FT596;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: Rituximab;   Drug: Bendamustine Sponsor:   Fate Therapeutics Withdrawn
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials